Equity markets witnessed a choppy session with sharp intraday swings in key benchmark indices, driven by the monthly F&O ...

A brutal sell-off has crushed sentiment, but the underlying business may be stronger than the share price suggests. The post Down 60%, is there a once-in-a-decade opportunity in this ASX 200 stock?

Market experts believe export-oriented firms in textiles, gems and jewellery, auto components, pharmaceuticals, IT and ...

Novo Nordisk (NVO) reached $62.89 at the closing of the latest trading day, reflecting a -1.7% change compared to its last close.

FRANKFURT: European equities ended higher on Tuesday, supported by a raft of positive corporate catalysts that ...

The KOSDAQ index recently surpassed the 1,000-point mark, drawing heightened market attention. Amid this, competition between ...

Lower prices from the third round of talks among Medicare and manufacturers will be announced in the fall but won’t go into ...

BD's board authorized the company to repurchase up to 10 million shares of its common stock in addition to those remaining under previous authorizations. The medical technology company said Tuesday it ...

Jan 27 (Reuters) - ‌The ​U.S. ‌Centers for ​Medicare & Medicaid ‍Services on ​Tuesday ​named a ⁠new group of branded drugs ...

Certain of AIM’s leadership have indicated to the Company on a non-binding basis that they intend to participate in the Rights Offering, including Board member and Chief Executive Officer Thomas K.

Clorox tops our list of the best dividend aristocrats to buy. Morningstar director Erin Lash expects mid-single-digit ...

Of the many options, the most satisfying in the opinion of C&EN’s business team is calcium chloride. The chemical is strongly ...